Patent · US Active

Targeting microRNAs for metabolic disorders

US9550996B2 · kind B2 · utility

1Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2015
Grant dateJan 24, 2017
Priority date—
Expiry dateDec 16, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/35
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods and compositions for the treatment of metabolic disorders. Also provided herein are methods and compositions for the reduction of blood glucose level, the reduction of gluconeogenesis, the improvement of insulin resistance and the reduction of plasma cholesterol level. In certain embodiments, the methods comprise inhibiting the activity of miR-103. In certain embodiments, the methods comprise inhibiting the activity of miR-107. In certain embodiments, the activity of both miR-103 and miR-107 is inhibited. In certain embodiments, such methods comprise administering a compound comprising an oligonucleotide targeted to a microRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.